ReviewModern rheumatology2008
Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs.
Review in Modern rheumatology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Meta-analysis and systematic review: the association between rheumatoid arthritis and the risk of thyroid cancer.Frontiers in immunology · 2026Pooled it
- Patterns of disease-modifying antirheumatic drug use in rheumatoid arthritis patients after 2002: a systematic review.Arthritis care & research · 2013Pooled it
- The multi-biomarker disease activity test for assessing response to treatment strategies using methotrexate with or without prednisone in the CAMERA-II trial.Arthritis research & therapy · 2020Trial
- Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial with etoricoxib.BMC musculoskeletal disorders · 2015Trial
- Remission is not maintained over 2 years with hematopoietic stem cell transplantation for rheumatoid arthritis: A systematic review with meta-analysis.World journal of biological chemistry · 2021Article
- Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity.The Journal of biological chemistry · 2018Article
- Use of biological disease modifying antirheumatic drugs in rheumatoid arthritis in Austria from 2008 to 2011 : A retrospective analysis of 72% of the population.Wiener klinische Wochenschrift · 2018Article
- Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients.PloS one · 2018Article
- Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability.PloS one · 2016Article
- Barriers to achieving controlled rheumatoid arthritis in the United Arab Emirates: a cross-sectional study.Rheumatology international · 2015Article
- Biomarkers predicting a need for intensive treatment in patients with early arthritis.Current pharmaceutical design · 2015Review
- Is there a link between amyotrophic lateral sclerosis and treatment with TNF-alpha inhibitors?Upsala journal of medical sciences · 2013Article
- Prescription for antiresorptive therapy in Mexican patients with rheumatoid arthritis: is it time to reevaluate the strategies for osteoporosis prevention?Rheumatology international · 2013Article
- The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.Rheumatology international · 2012Article
- Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis.Arthritis care & research · 2011Article
- Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis.Arthritis and rheumatism · 2011Article
- The Japanese experience with biologic therapies for rheumatoid arthritis.Nature reviews. Rheumatology · 2010Review
- Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study.Arthritis research & therapy · 2010Article
- Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell lines.Pharmacogenomics · 2009Article
- Current status of gene therapy for rheumatoid arthritis.Current rheumatology reports · 2008Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Modern therapy for rheumatoid arthritis (RA) is based on knowledge of the severity of the natural history of the disease. RA patients are approached with early and aggressive treatment strategies, methotrexate as an anchor drug, biological targeted therapies in those with inadequate response to methotrexate, and "tight control," aiming for remission and low disease activity according to quantitative monitoring. This chapter presents a rationale for current treatment strategies for RA with antirheumatic drugs, a review of published reports concerning treatments in clinical cohorts outside of clinical trials, and current treatments at 61 sites in 21 countries in the QUEST-RA database.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.